Bioresorbable scaffolds for the treatment of complex lesions: are we there yet?

摘要

The introduction of bioresorbable vascular scaffolds (BRS) is changing the landscape of percutaneous coronary revascularization and is considered by many the 4th revolution in interventional cardiology. To date, BRS have shown promising short- and long-term results in the treatment of simple de novo lesions. Even though the feasibility, efficacy and safety of BRS implantation for more complex lesion subsets remain unknown, reports are emerging aiming to identify the role of BRS in everyday practice. In the current review we are aiming to summarize the results from 'all-comer' BRS studies and identify strengths and limitations of BRS when tackling specific complex lesion subsets.